IL171185A - Drug-borne particles whose tumors @ target - Google Patents
Drug-borne particles whose tumors @ targetInfo
- Publication number
- IL171185A IL171185A IL171185A IL17118505A IL171185A IL 171185 A IL171185 A IL 171185A IL 171185 A IL171185 A IL 171185A IL 17118505 A IL17118505 A IL 17118505A IL 171185 A IL171185 A IL 171185A
- Authority
- IL
- Israel
- Prior art keywords
- tumor
- targeting drug
- loaded particles
- loaded
- particles
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46082703P | 2003-04-03 | 2003-04-03 | |
| PCT/US2004/010230 WO2004089291A2 (en) | 2003-04-03 | 2004-04-02 | Tumor-targeting drug-loaded particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL171185A true IL171185A (en) | 2013-07-31 |
Family
ID=33159807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL171185A IL171185A (en) | 2003-04-03 | 2005-09-29 | Drug-borne particles whose tumors @ target |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1608359A4 (de) |
| JP (1) | JP4927535B2 (de) |
| KR (1) | KR100849911B1 (de) |
| CN (2) | CN102697737B (de) |
| AU (1) | AU2004228008B2 (de) |
| CA (1) | CA2520475C (de) |
| IL (1) | IL171185A (de) |
| WO (1) | WO2004089291A2 (de) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007526322A (ja) * | 2004-03-02 | 2007-09-13 | マサチューセッツ インスティテュート オブ テクノロジー | ナノセル薬物送達系 |
| ES2557988T3 (es) * | 2005-03-31 | 2016-02-01 | Lidds Ab | Método para tratar enfermedades de próstata basado en el suministro local de principios activos |
| BRPI0600285C1 (pt) * | 2006-01-13 | 2011-10-11 | Brz Biotecnologia Ltda | compostos farmacêuticos contendo nanopartìculas úteis para tratamento de lesões reestenóticas |
| JP2007277217A (ja) * | 2006-03-17 | 2007-10-25 | Fujifilm Corp | 薬剤を均一に封入した生分解性マトリックス |
| US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
| US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
| EP2092942A1 (de) * | 2006-11-20 | 2009-08-26 | Lutonix, Inc. | Wirkstofffreisetzende Beschichtungen für medizinische Vorrichtungen |
| US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
| US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US8414909B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| EP2074988B1 (de) | 2007-12-28 | 2018-03-14 | Industrial Technology Research Institute | Zusammensetzung mit verzögerter Freisetzung und Herstellungsverfahren dafür |
| US9161943B2 (en) | 2007-12-31 | 2015-10-20 | Industrial Technology Research Institute | Sustained release composition and manufacturing method thereof |
| WO2009116556A1 (ja) * | 2008-03-19 | 2009-09-24 | 富士フイルム株式会社 | 注射用医薬組成物 |
| US8613951B2 (en) | 2008-06-16 | 2013-12-24 | Bind Therapeutics, Inc. | Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same |
| JP2012501965A (ja) | 2008-06-16 | 2012-01-26 | バインド バイオサイエンシズ インコーポレイテッド | 薬剤を装填したポリマーナノ粒子及びその製造方法と使用方法 |
| ES2721850T3 (es) | 2008-06-16 | 2019-08-05 | Pfizer | Nanopartículas poliméricas terapéuticas que comprenden alcaloides vinca y procedimientos de fabricación y uso de las mismas |
| WO2010068866A2 (en) | 2008-12-12 | 2010-06-17 | Bind Biosciences | Therapeutic particles suitable for parenteral administration and methods of making and using same |
| US20100216804A1 (en) | 2008-12-15 | 2010-08-26 | Zale Stephen E | Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents |
| US8357401B2 (en) | 2009-12-11 | 2013-01-22 | Bind Biosciences, Inc. | Stable formulations for lyophilizing therapeutic particles |
| ES2780156T3 (es) | 2009-12-15 | 2020-08-24 | Pfizer | Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular |
| KR101314579B1 (ko) * | 2011-04-07 | 2013-10-10 | 광주과학기술원 | 파크리탁셀이 선적된 고분자 나노입자 및 그 제조방법 |
| JP2013053103A (ja) * | 2011-09-05 | 2013-03-21 | Ltt Bio-Pharma Co Ltd | 薬物を封入した肝臓集積性ナノ粒子 |
| WO2013124867A1 (en) * | 2012-02-21 | 2013-08-29 | Amrita Vishwa Vidyapeetham University | Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules |
| MX356097B (es) | 2012-09-17 | 2018-05-14 | Pfizer Inc Star | Proceso para la preparacion de nanoparticulas terapeuticas. |
| US10143700B2 (en) | 2013-02-19 | 2018-12-04 | Amrita Vishwa Vidyapeetham | Nanoparticle formulations for delivering multiple therapeutic agents |
| ES2640648T3 (es) | 2013-09-16 | 2017-11-03 | Astrazeneca Ab | Nanopartículas poliméricas terapéuticas y métodos para su fabricación y uso |
| MA39734B1 (fr) | 2014-03-14 | 2019-07-31 | Pfizer | Nanoparticules thérapeutiques comportant un agent thérapeutique, et leurs procédés de fabrication et d'utilisation |
| WO2016111913A1 (en) * | 2015-01-05 | 2016-07-14 | Boston Scientific Scimed, Inc. | Biodegradable drug eluting microsphere for the treatment of solid tumors |
| GB201505527D0 (en) | 2015-03-31 | 2015-05-13 | Jmedtech Pte Ltd | Composition |
| EP3302423B1 (de) | 2015-06-04 | 2022-05-25 | Crititech, Inc. | Partikelproduktionssystem und partikelsammelvorrichtung |
| US20170128424A1 (en) * | 2015-11-11 | 2017-05-11 | Qrono, Inc. | Sustained release pharmaceutical compositions and methods of use |
| BR112018069628A2 (pt) | 2016-04-04 | 2019-02-12 | Crititech, Inc. | métodos para tratamento de tumor sólido |
| CN106075535B (zh) * | 2016-06-14 | 2019-04-02 | 武汉纺织大学 | 一种医用敷料及其制备方法 |
| WO2018011040A1 (en) * | 2016-07-13 | 2018-01-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Plga microparticles loaded with a fluoroquinolone for the treatment of respiratory diseases |
| US10993919B2 (en) | 2016-10-04 | 2021-05-04 | University Of Florida Research Foundation, Inc. | Chondroprotective nanoparticles for the treatment of osteoarthritis |
| CN107049984A (zh) * | 2017-03-14 | 2017-08-18 | 武汉理工大学 | 一种载紫杉醇聚乳酸‑羟基乙酸微球的制备方法 |
| KR102024273B1 (ko) * | 2017-03-27 | 2019-11-04 | 주식회사 피에프디 | 약물 작용 관리 장치 및 방법 |
| EP3615145B1 (de) | 2017-06-09 | 2024-05-15 | Crititech, Inc. | Zusammensetzungen zur verwendung bei der behandlung von epithelzysten durch intracystische injektion antineoplastischer partikeln |
| WO2018231908A1 (en) | 2017-06-14 | 2018-12-20 | Crititech, Inc. | Methods for treating lung disorders |
| KR20250057947A (ko) | 2017-10-03 | 2025-04-29 | 크리티테크, 인크. | 암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달 |
| WO2019071245A1 (en) | 2017-10-06 | 2019-04-11 | Foundry Therapeutics, Inc. | IMPLANTABLE DEPOSITS FOR REGULATED RELEASE OF ANALGESICS TO TREAT POSTHOPERATIVE PAIN ASSOCIATED WITH ORTHOPEDIC SURGERY, AND RELATED DEVICES, SYSTEMS, AND METHODS |
| SG11202005672PA (en) * | 2018-01-05 | 2020-07-29 | Crititech Inc | Treatment of bladder cancer by local administration of taxane particles |
| WO2019136490A1 (en) | 2018-01-08 | 2019-07-11 | Foundry Therapeutics, Inc. | Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents |
| GB201800912D0 (en) * | 2018-01-19 | 2018-03-07 | Ucl Business Plc | Compositions for the treatment of a disease of the urinary tract and treatment of a disease involving the intracellular delivery of the particle |
| EP3793536A1 (de) | 2018-05-12 | 2021-03-24 | Foundry Therapeutics, Inc. | Implantierbare polymerdepots zur kontrollierten freisetzung von therapeutika |
| WO2019231499A1 (en) * | 2018-05-31 | 2019-12-05 | Crititech, Inc. | Use of antineoplastic agents to stimulate the immune system for treatment of cancer |
| US12303619B2 (en) | 2018-08-28 | 2025-05-20 | Foundry Therapeutics, Inc. | Polymer implants |
| WO2020072090A1 (en) * | 2018-10-03 | 2020-04-09 | Crititech, Inc. | Use of antineoplastic agents to stimulate the immune system for production of tertiary lymphoid structures (tls) |
| EP3750523A1 (de) * | 2019-06-13 | 2020-12-16 | CAPNOMED GmbH | System zur abgabe eines wirkstoffes |
| EP3750524A1 (de) * | 2019-06-13 | 2020-12-16 | CAPNOMED GmbH | Verzögerte und anhaltende abgabe von antikrebsmitteln |
| EP3791865A1 (de) * | 2019-09-16 | 2021-03-17 | CAPNOMED GmbH | Wirkstoffabgabesystem mit verzögerter abgabe |
| WO2022075318A1 (ja) * | 2020-10-08 | 2022-04-14 | 学校法人関西医科大学 | がん治療用組成物の有効性を反映する評価マーカー |
| US20240016774A1 (en) * | 2020-10-14 | 2024-01-18 | Foundry Therapeutics, Inc. | Implantable depots for localized, sustained, controlled release of therapeutic agents to treat cancer and related conditions |
| US20240307220A1 (en) * | 2021-03-05 | 2024-09-19 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Combination Therapy to Treat Temperature Sensitive Mutant Tumors |
| CN115770224B (zh) * | 2023-01-17 | 2023-04-18 | 中国人民解放军总医院第一医学中心 | 一种携载紫杉醇药物的丙烯酸微球及其制备方法 |
| CN118649148B (zh) * | 2024-05-30 | 2024-11-01 | 河南中医药大学第一附属医院 | 一种黄芪多糖复合纳米颗粒及其制备方法、应用 |
| CN118948780B (zh) * | 2024-08-07 | 2025-07-15 | 山东序列生物科技有限公司 | 一种罗西维林冻干制剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en) * | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| US20020164374A1 (en) * | 1997-10-29 | 2002-11-07 | John Jackson | Polymeric systems for drug delivery and uses thereof |
| WO2000061141A2 (en) * | 1999-04-09 | 2000-10-19 | Au Jessie L S | Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| US6287588B1 (en) * | 1999-04-29 | 2001-09-11 | Macromed, Inc. | Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof |
| US6444227B1 (en) * | 1999-08-05 | 2002-09-03 | Roche Vitamins Inc. | Process for preparing fat soluble beadlets |
| EP1343478B1 (de) * | 2000-12-21 | 2007-10-10 | Alrise Biosystems GmbH | Induziertes phasenübergangs verfahren zur herstellung von hydrophile wirkstoffe enthaltende mikropartikeln |
| US20020192280A1 (en) * | 2001-05-01 | 2002-12-19 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents |
-
2004
- 2004-04-02 EP EP04758803A patent/EP1608359A4/de not_active Withdrawn
- 2004-04-02 CA CA2520475A patent/CA2520475C/en not_active Expired - Fee Related
- 2004-04-02 KR KR1020057018841A patent/KR100849911B1/ko not_active Expired - Fee Related
- 2004-04-02 CN CN201210204260.1A patent/CN102697737B/zh not_active Expired - Fee Related
- 2004-04-02 WO PCT/US2004/010230 patent/WO2004089291A2/en not_active Ceased
- 2004-04-02 JP JP2006509638A patent/JP4927535B2/ja not_active Expired - Fee Related
- 2004-04-02 AU AU2004228008A patent/AU2004228008B2/en not_active Ceased
- 2004-04-02 CN CN2004800156847A patent/CN1816331B/zh not_active Expired - Fee Related
-
2005
- 2005-09-29 IL IL171185A patent/IL171185A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1816331A (zh) | 2006-08-09 |
| AU2004228008B2 (en) | 2008-11-06 |
| JP4927535B2 (ja) | 2012-05-09 |
| JP2006522148A (ja) | 2006-09-28 |
| KR20060006911A (ko) | 2006-01-20 |
| CN102697737A (zh) | 2012-10-03 |
| CN1816331B (zh) | 2012-08-08 |
| WO2004089291A3 (en) | 2005-04-21 |
| CN102697737B (zh) | 2014-03-19 |
| EP1608359A4 (de) | 2011-08-17 |
| WO2004089291A2 (en) | 2004-10-21 |
| KR100849911B1 (ko) | 2008-08-04 |
| CA2520475C (en) | 2012-10-09 |
| CA2520475A1 (en) | 2004-10-21 |
| AU2009200463A1 (en) | 2009-03-05 |
| AU2004228008A1 (en) | 2004-10-21 |
| EP1608359A2 (de) | 2005-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL171185A (en) | Drug-borne particles whose tumors @ target | |
| AU2003293294A8 (en) | Uv-stabilised particles | |
| DK1889621T3 (da) | Multipartikler | |
| GB2401547B (en) | Particulate materials | |
| GB0216197D0 (en) | Serrs active particles | |
| GB0426043D0 (en) | Antibodies | |
| GB0223127D0 (en) | nanoparticles | |
| GB2398241B (en) | Particle formation | |
| IL176165A0 (en) | Cffdinir oral suspension | |
| GB2391174B (en) | Particle formation | |
| EP1699435A4 (de) | Partikel | |
| GB0223149D0 (en) | Nanoparticles | |
| GB0402043D0 (en) | Differential | |
| GB0324147D0 (en) | Functionilisation of particles | |
| GB0300338D0 (en) | Particle formation | |
| GB0201382D0 (en) | Virus-like particles | |
| GB0229662D0 (en) | Nanostructures | |
| AP2059A (en) | Heavy particle separation | |
| GB0329208D0 (en) | Particulate materials | |
| HK1087013A (en) | Tumor-targeting drug-loaded particles | |
| GB0518478D0 (en) | Particles | |
| AU2009200463B2 (en) | Tumor-Targeting Drug Loaded Particles | |
| ZA200408974B (en) | Pesticidal particle | |
| GB0321873D0 (en) | Particles | |
| GB0328397D0 (en) | Particles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |